Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
trend decrease » teer decrease (Expand Search)
Showing 1,461 - 1,480 results of 14,993 for search '(( significant ((trend decrease) OR (mean decrease)) ) OR ( significant increase decrease ))', query time: 0.43s Refine Results
  1. 1461
    The mean number of the emerged <i>D. melanogaster</i> adults. Mean number (±SE) of emerged adults and average percentage (±SE) of the residual fertility at the different treatment doses (Gy).

    The mean number of the emerged <i>D. melanogaster</i> adults. Mean number (±SE) of emerged adults and average percentage (±SE) of the residual fertility at the different treatment... by Flavia Cerasti (21655934)

    Published 2025
    Save to List
    Saved in:
  2. 1462
    KO of iPLA<sub>2</sub>γ attenuates development of albuminuria in STZ-induced diabetic nephropathy.

    KO of iPLA<sub>2</sub>γ attenuates development of albuminuria in STZ-induced diabetic nephropathy. by Andrey V. Cybulsky (4007012)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 1463
    Boxplots display the median (as the central tendency) and the interquartile range (25th to 75th percentiles) as the bottom and top edges of the box.

    Boxplots display the median (as the central tendency) and the interquartile range (25th to 75th percentiles) as the bottom and top edges of the box. by Manal Ali Ahmad (16868808)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1464
    Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells).

    Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells). by Andrey V. Cybulsky (4007012)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 1465
    Comparing detector performance against increasing signal to noise ratios.

    Comparing detector performance against increasing signal to noise ratios. by Bernd Porr (32394)

    Published 2024
    Save to List
    Saved in:
  6. 1466
    A) RT-qPCR analysis of <i>Yap</i>, <i>Taz</i>, and <i>Tead2</i> shows a significant decrease in transcript levels over postnatal stages from P0 to P28.

    A) RT-qPCR analysis of <i>Yap</i>, <i>Taz</i>, and <i>Tead2</i> shows a significant decrease in transcript levels over postnatal stages from P0 to P28. by Heather L. Dingwall (14573796)

    Published 2025
    Save to List
    Saved in:
  7. 1467
    Long-term trajectories of ABG parameters.

    Long-term trajectories of ABG parameters. by Kazuma Nagata (3400058)

    Published 2025
    Save to List
    Saved in:
  8. 1468
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1469
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1470
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1471
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1472
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1473
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1474
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1475
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1476
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1477
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1478
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1479
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1480
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: